Last reviewed · How we verify
NCT06769737
The Prolonging Effect of Dexmedetomidine on Spinal Anesthesia Through Different Routes if Administrations
Phase 4 trial testing Interventional group#1 in Spinal Anesthesia Evaluation in 75 participants. Not yet recruiting.
15 August 2025
Quick facts
| Lead sponsor | King Abdulaziz Medical City |
|---|---|
| Phase | Phase 4 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 75 |
| Start date | 1 March 2025 |
| Primary completion | 15 August 2025 |
| Estimated completion | 1 September 2025 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Interventional group#1 — full drug profile →
- Interventional group#2 — full drug profile →
Conditions studied
- Spinal Anesthesia Evaluation — all drugs for Spinal Anesthesia Evaluation →
Sponsor
King Abdulaziz Medical City — full company profile →
Who can join
Adults 18 to 80, any sex, with Spinal Anesthesia Evaluation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective, double-blinded, randomized clinical trial aims to examine the effects of combining isobaric bupivacaine with dexmedetomidine administered intrathecally (IT), compared to the combination of isobaric bupivacaine administered intrathecally and dexmedetomidine administered intravenously (IV), on spinal anesthesia prolongation time in minutes, time of regression from Bromage score 3 to 0.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06769737
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Spinal Anesthesia Evaluation
Currently open trials in the same condition.
- NCT07197398 — Preoperative Data and the Spinal Spread of Local Anesthetic in Cesarean Section · recruiting
- NCT06988982 — Lipid Emulsion for Reversal of Spinal Anesthesia in Ambulatory Surgery · NA · recruiting
Other King Abdulaziz Medical City trials
Trials by the same sponsor.
- NCT06109597 — Risk Factors and Diagnostic Performance of Predictors as a Screening Technique for Gestational Diabetes Mellitus · completed
- NCT05488834 — Nurse-led Pain Management in Adult ICU · NA · completed
- NCT04921462 — Silastic Sheet Usefulness Following Septoplasty · NA · completed
- NCT04579419 — Injection Site Pain Botulinum Toxin Reconstituted in NS With and Without Sodium Bicarbonate · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06769737 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King Abdulaziz Medical City
- Last refreshed: 10 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06769737.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing